Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PaworZhin is a combination pharmaceutical and nutraceutical product developed by Sepidaj Pharmaceutical. It is formulated as a soft gel capsule containing a standardized extract of *Panax ginseng* (typically 100 mg) along with a comprehensive complex of essential vitamins (including A, B-complex, C, D3, and E) and minerals (such as iron, zinc, magnesium, and calcium). The product is primarily indicated as an adaptogen to enhance physical and mental performance, improve concentration, and combat fatigue or exhaustion, particularly in the elderly or during recovery from illness. The ginseng component, rich in ginsenosides, is believed to modulate the hypothalamic-pituitary-adrenal (HPA) axis and interact with various steroid hormone receptors to improve stress resistance, while the vitamin and mineral components serve as essential cofactors for cellular metabolism and enzymatic functions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ginseng + multivitamins + minerals.